Prunus africanum (Hook f.) Kalkman (syn. Pygeum africanum Hook. f.)

2010 ◽  
pp. 554-557
Keyword(s):  
Pygeum Africanum

Effect of Pygeum africanum tadenan on micturition and prostate growth of the rat secondary to coadministered treatment and post-treatment with dihydrotestosterone

Urology ◽  
2003 ◽  
Vol 61 (2) ◽  
pp. 474-478 ◽  
Author(s):  
Yosh Yoshimura ◽  
Osamu Yamaguchi ◽  
Francois Bellamy ◽  
Christos E Constantinou
Keyword(s):  
Post Treatment ◽  
Prostate Growth ◽  
Pygeum Africanum

Inhibition of bFGF and EGF-induced proliferation of 3T3 fibroblasts by extract of Pygeum africanum (Tadenan®)

1994 ◽  
Vol 48 ◽  
pp. 43s-47s ◽  
Author(s):  
M. Paubert-Braquet ◽  
J.C. Monboisse ◽  
N. Servent-Saez ◽  
A. Serikoff ◽  
A. Cavé ◽  
...  
Keyword(s):  
3T3 Fibroblasts ◽  
Pygeum Africanum

Review of the experience and evidence of Pygeum africanum in urological practice

2020 ◽  
Vol 44 (1) ◽  
pp. 9-13
Author(s):  
J. Salinas-Casado ◽  
M. Esteban-Fuertes ◽  
J. Carballido-Rodríguez ◽  
J.M. Cozar-Olmo
Keyword(s):  
Pygeum Africanum

Pygeum africanum: effect on oxidative stress in early diabetes-induced bladder

2009 ◽  
Vol 42 (2) ◽  
pp. 401-408 ◽  
Author(s):  
Dan Wang ◽  
Yongzhi Li ◽  
Guihua Hou ◽  
Ping Wang ◽  
Jianping Zhang ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Early Diabetes ◽  
Pygeum Africanum

A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS

2007 ◽  
Vol 26 (4) ◽  
pp. 458-463 ◽  
Author(s):  
Alan D. Edgar ◽  
Robert Levin ◽  
Christos E. Constantinou ◽  
Louis Denis
Keyword(s):  
Plant Extract ◽  
Critical Review ◽  
Pygeum Africanum

Effects on Sexual Function by the Drugs used in the Treatment of Benign Prostatic Hyperplasia and Prostate Cancer. A Practical Guide for the Urologist

2005 ◽  
Vol 72 (2) ◽  
pp. 229-237
Author(s):  
F. Di Tonno ◽  
C. Mazzariol ◽  
N. Piazza ◽  
S. Omacini ◽  
G. Malossini ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Benign Prostatic Hyperplasia ◽  
Sexual Function ◽  
Erectile Function ◽  
Cyproterone Acetate ◽  
Hypotensive Effect ◽  
Prostatic Hyperplasia ◽  
Serenoa Repens ◽  
Lh Rh ◽  
Pygeum Africanum

The effects on sexual function (SF) by the drugs commonly used in the treatment of benign prostatic hyperplasia (BPH) and prostate cancer (PC) have been analyzed. BPH therapy: alpha-blockers have no adverse effects on SF; the only one without significant hypotensive effect, Tamsulosin, can cause retrograde ejaculation in 4–8% of cases. 5-Alpha-reductase (Finasteride and Dutasteride) inhibitors could have detrimental effects on erectile function, libido and ejaculation in a small percentage of cases rarely exceeding 10%; these effects are reversible and their incidence reduces after 1 yr. Phytotherapy (extracts from pygeum africanum and serenoa repens) and mepartricin have no unfavorable action on SF. PC therapy: Loss of erectile function and libido are the norm with the use of LH-RH analogues, estrogens and steroidal antiandrogens (cyproterone acetate). Non-steroidal antiandrogens (Flutamide, Bicalutamide and Nilutamide) allow the preservation of SF in two-thirds of cases.

Sign in / Sign up

Export Citation Format

Share Document